vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and WM TECHNOLOGY, INC. (MAPS). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $43.1M, roughly 1.4× WM TECHNOLOGY, INC.). WM TECHNOLOGY, INC. runs the higher net margin — -8.3% vs -70.9%, a 62.6% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -9.7%). WM TECHNOLOGY, INC. produced more free cash flow last quarter ($-280.0K vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -1.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.
CTKB vs MAPS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $43.1M |
| Net Profit | $-44.1M | $-3.6M |
| Gross Margin | 52.9% | 94.9% |
| Operating Margin | -9.0% | -13.5% |
| Net Margin | -70.9% | -8.3% |
| Revenue YoY | 8.1% | -9.7% |
| Net Profit YoY | -557.1% | -251.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $43.1M | ||
| Q3 25 | $52.3M | $42.2M | ||
| Q2 25 | $45.6M | $44.8M | ||
| Q1 25 | $41.5M | $44.6M | ||
| Q4 24 | $57.5M | $47.7M | ||
| Q3 24 | $51.5M | $46.6M | ||
| Q2 24 | $46.6M | $45.9M | ||
| Q1 24 | $44.9M | $44.4M |
| Q4 25 | $-44.1M | $-3.6M | ||
| Q3 25 | $-5.5M | $2.5M | ||
| Q2 25 | $-5.6M | $1.4M | ||
| Q1 25 | $-11.4M | $1.6M | ||
| Q4 24 | $9.6M | $2.4M | ||
| Q3 24 | $941.0K | $3.3M | ||
| Q2 24 | $-10.4M | $716.0K | ||
| Q1 24 | $-6.2M | $1.2M |
| Q4 25 | 52.9% | 94.9% | ||
| Q3 25 | 52.7% | 95.0% | ||
| Q2 25 | 52.3% | 94.9% | ||
| Q1 25 | 48.6% | 95.0% | ||
| Q4 24 | 58.5% | 95.2% | ||
| Q3 24 | 56.3% | 95.3% | ||
| Q2 24 | 54.6% | 95.1% | ||
| Q1 24 | 51.3% | 94.8% |
| Q4 25 | -9.0% | -13.5% | ||
| Q3 25 | -17.6% | 4.6% | ||
| Q2 25 | -23.3% | 4.4% | ||
| Q1 25 | -36.1% | 5.9% | ||
| Q4 24 | 5.2% | 9.6% | ||
| Q3 24 | -8.2% | 11.2% | ||
| Q2 24 | -18.3% | 2.7% | ||
| Q1 24 | -23.9% | 8.5% |
| Q4 25 | -70.9% | -8.3% | ||
| Q3 25 | -10.5% | 5.8% | ||
| Q2 25 | -12.2% | 3.2% | ||
| Q1 25 | -27.5% | 3.7% | ||
| Q4 24 | 16.8% | 4.9% | ||
| Q3 24 | 1.8% | 7.2% | ||
| Q2 24 | -22.4% | 1.6% | ||
| Q1 24 | -13.8% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $0.02 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $62.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $57.2M |
| Total Assets | $461.5M | $190.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $62.4M | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | $52.0M | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $57.2M | ||
| Q3 25 | $378.6M | $56.9M | ||
| Q2 25 | $377.6M | $52.7M | ||
| Q1 25 | $379.6M | $48.5M | ||
| Q4 24 | $395.7M | $36.1M | ||
| Q3 24 | $385.5M | $29.5M | ||
| Q2 24 | $389.1M | $24.5M | ||
| Q1 24 | $392.6M | $20.8M |
| Q4 25 | $461.5M | $190.7M | ||
| Q3 25 | $494.9M | $192.9M | ||
| Q2 25 | $493.3M | $188.1M | ||
| Q1 25 | $482.6M | $183.8M | ||
| Q4 24 | $499.5M | $181.9M | ||
| Q3 24 | $491.2M | $173.6M | ||
| Q2 24 | $483.7M | $168.0M | ||
| Q1 24 | $492.1M | $165.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $3.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $-280.0K |
| FCF MarginFCF / Revenue | -2.9% | -0.7% |
| Capex IntensityCapex / Revenue | 1.6% | 7.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $3.0M | ||
| Q3 25 | $-3.9M | $6.4M | ||
| Q2 25 | $108.0K | $11.1M | ||
| Q1 25 | $-125.0K | $5.7M | ||
| Q4 24 | $2.0M | $9.4M | ||
| Q3 24 | $13.2M | $7.2M | ||
| Q2 24 | $6.2M | $12.7M | ||
| Q1 24 | $4.0M | $7.4M |
| Q4 25 | $-1.8M | $-280.0K | ||
| Q3 25 | $-4.6M | $3.6M | ||
| Q2 25 | $-1.5M | $8.2M | ||
| Q1 25 | $-974.0K | $2.0M | ||
| Q4 24 | $1.1M | $7.3M | ||
| Q3 24 | $12.2M | $4.9M | ||
| Q2 24 | $5.2M | $10.1M | ||
| Q1 24 | $3.4M | $2.9M |
| Q4 25 | -2.9% | -0.7% | ||
| Q3 25 | -8.7% | 8.4% | ||
| Q2 25 | -3.2% | 18.3% | ||
| Q1 25 | -2.3% | 4.5% | ||
| Q4 24 | 1.9% | 15.2% | ||
| Q3 24 | 23.7% | 10.4% | ||
| Q2 24 | 11.0% | 21.9% | ||
| Q1 24 | 7.6% | 6.4% |
| Q4 25 | 1.6% | 7.7% | ||
| Q3 25 | 1.3% | 6.8% | ||
| Q2 25 | 3.5% | 6.3% | ||
| Q1 25 | 2.0% | 8.2% | ||
| Q4 24 | 1.6% | 4.5% | ||
| Q3 24 | 2.0% | 5.1% | ||
| Q2 24 | 2.3% | 5.7% | ||
| Q1 24 | 1.3% | 10.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.61× | ||
| Q2 25 | — | 7.75× | ||
| Q1 25 | — | 3.44× | ||
| Q4 24 | 0.21× | 4.00× | ||
| Q3 24 | 14.05× | 2.17× | ||
| Q2 24 | — | 17.67× | ||
| Q1 24 | — | 5.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MAPS
| Services | $39.5M | 92% |
| Other | $3.6M | 8% |
